Skip to main content
SpringerLink
Log in

Sars-cov-2-vaccine-inactivated-sinovac-biotech

Vaccine-associated disease enhancement of COVID-19 pneumonia: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tunjungputri RN, et al. Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19. Case Reports in Medicine 2021: 9673453, 2021. Available from: URL: http://www.hindawi.com/journals/crim/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sars-cov-2-vaccine-inactivated-sinovac-biotech. Reactions Weekly 1886, 358 (2021). https://doi.org/10.1007/s40278-021-07623-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-07623-0

Search

Navigation